Wai Conrad
Known title: CEO, Counterpart HealthCIK: 0001971702
Associated companies
Transaction History
| CLOV | ▼ Sell | Open Market | 300,000 | $1.4M | 9/15/2026 | View on chart |
| CLOV | ▼ Sell | Open Market | 24,215 | $113K | 7/15/2026 | View on chart |
| CLOV | ▼ Sell | Open Market | 220,426 | $879K | 5/28/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 23,463 | $48K | 4/15/2026 | View on chart |
| CLOV | ▲ Buy | Grant | 267,766 | $0 | 4/1/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 100,195 | $198K | 3/14/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 25,868 | $73K | 1/15/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 98,411 | $266K | 12/14/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 96,448 | $340K | 10/31/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 27,930 | $99K | 10/31/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 92,181 | $258K | 10/15/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 98,412 | $301K | 9/14/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 27,930 | $81K | 7/31/2025 | View on chart |
| CLOV | ▼ Sell | Open Market | 91,197 | $303K | 7/23/2025 | View on chart |
| CLOV | ▼ Sell | Open Market | 118,600 | $390K | 7/22/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 98,411 | $284K | 6/14/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 26,593 | $90K | 4/30/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 80,524 | $295K | 3/14/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 24,470 | $107K | 1/31/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 98,217 | $305K | 12/14/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 111,496 | $459K | 10/31/2024 | View on chart |
| CLOV | ▲ Buy | Grant | 726,114 | $0 | 10/15/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 98,217 | $294K | 9/14/2024 | View on chart |
| CLOV | ▲ Buy | Grant | 189,934 | $0 | 9/13/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 93,180 | $279K | 9/13/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 69,148 | $75K | 6/14/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 74,396 | $54K | 3/14/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 96,086 | $96K | 12/14/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 96,086 | $109K | 9/14/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 86,763 | $82K | 6/14/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.